Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients

NCT06315023 is registered in ClinicalTrials.gov with Endologix as lead sponsor.

NCT NCT06315023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06315023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients
Lead sponsor
Endologix
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 6, 2023
Completion date
June 7, 2032
Enrollment
450 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, symptomatic femoropopliteal lesions